Difference between revisions of "HYPERPARATHYROIDISM-PRIMARY, MANAGEMENT"

From NeuroRehab.wiki

(Imported from text file)
 
(Imported from text file)
 
Line 2: Line 2:
1. Symptomatic patients: surgery. Do US and sestamibi scans to localize adenomas.  
1. Symptomatic patients: surgery. Do US and sestamibi scans to localize adenomas.  
<br/>
<br/>
<br/>2. Other indications for surgery
<br/>2. Other indications for surgery  
<br/>- CKD stage 3
<br/>- CKD stage 3
<br/>- T-score &lt; -2.5  
<br/>- T-score &lt; -2.5  
Line 10: Line 10:
<br/>2. Bisphophonates: build bone.  
<br/>2. Bisphophonates: build bone.  
<br/>
<br/>
<br/>3. Following treatment - do yearly serum calcium, 1-2 yearly bone scans.  
<br/>3. Following treatment: do yearly serum calcium, 1-2 yearly bone scans.  





Latest revision as of 02:29, 21 March 2023

SUMMARY

1. Symptomatic patients: surgery. Do US and sestamibi scans to localize adenomas.

2. Other indications for surgery
- CKD stage 3
- T-score < -2.5
- Z-score < -2.5 in premenopausal women, men < 50 years.
- Age < 50 years.

2. Bisphophonates: build bone.

3. Following treatment: do yearly serum calcium, 1-2 yearly bone scans.


Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].